Adaptive Biotechnologies ... (ADPT)
NASDAQ: ADPT
· Real-Time Price · USD
13.03
0.11 (0.85%)
At close: Aug 15, 2025, 3:59 PM
13.05
0.15%
After-hours: Aug 15, 2025, 07:25 PM EDT
Adaptive Biotechnologies Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -121.26M | -141.89M | -159.59M | -195.32M | -213.52M | -215.11M | -225.28M | -196.01M | -191M | -195.27M | -200.37M | -221.56M | -232.24M | -229.45M | -207.3M | -190.51M | -171.23M | -155.47M |
Depreciation & Amortization | 18.27M | 18.77M | 19.26M | 20.2M | 21.37M | 22.02M | 22.23M | 22.13M | 21.75M | 21.29M | 20.92M | 20.48M | 18.63M | 16.34M | 13.95M | 11.46M | 10.07M | 9.16M |
Stock-Based Compensation | 51.86M | 51.46M | 53.61M | 56.33M | 58.15M | 62.53M | 62.91M | 61.65M | 60.45M | 57.29M | 55.48M | 53.06M | 50.56M | 47.63M | 43.25M | 38.62M | 33.45M | 28.57M |
Other Working Capital | -2.38M | -5.56M | 4.04M | -2.59M | -25.75M | -30.23M | -52.24M | -53.29M | -63.82M | -72.5M | -53.36M | -61.04M | -51.69M | -54.87M | -59.32M | -58.81M | -56.17M | -46.9M |
Other Non-Cash Items | -39.87M | -10.08M | 7.82M | 55.79M | 80.04M | 57.99M | 58.55M | 10.74M | 9.51M | 11.59M | 11.29M | 11.94M | 11.23M | 7.86M | 6.95M | 7.57M | 6.85M | 5.64M |
Deferred Income Tax | n/a | n/a | n/a | -23.79M | -26.31M | -28.55M | -28.55M | -4.76M | -2.24M | n/a | n/a | 1.28M | 3.06M | 5.13M | 7.23M | 7.07M | 5.98M | 2.43M |
Change in Working Capital | 10.53M | 13.36M | 3.05M | -3.51M | -29.64M | -32.01M | -46.18M | -53.15M | -53.88M | -73.81M | -71.55M | -73.23M | -60.03M | -46.44M | -56.82M | -52.95M | -67.57M | -66.67M |
Operating Cash Flow | -80.47M | -85.34M | -95.21M | -109.65M | -129.27M | -135.53M | -156.32M | -159.41M | -155.13M | -178.64M | -183.94M | -207.75M | -208.79M | -198.94M | -192.73M | -178.75M | -182.46M | -176.32M |
Capital Expenditures | -2.34M | -3.41M | -3.66M | -4.88M | -7.32M | -9.28M | -10.7M | -11.94M | -14.6M | -16.2M | -16.35M | -23.05M | -32.24M | -48.98M | -61.75M | -61.87M | -51.46M | -31.68M |
Cash Acquisitions | n/a | n/a | n/a | -4.5M | -33.42M | -74.44M | -74.44M | 25.07M | 53.98M | 84.96M | 84.96M | -10.04M | -10.04M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -209.85M | -241.43M | -244.26M | -321.45M | -377.28M | -393.94M | -429.56M | -472.6M | -382.07M | -307.64M | -278.78M | -192.29M | -305.38M | -361.44M | -316.54M | -633.18M | -683.57M | -602.56M |
Sales Maturities Of Investments | 268.51M | 303.7M | 325.71M | 385.21M | 464.32M | 514.4M | 569.9M | 513.43M | 457.43M | 352.03M | 298.03M | 383M | 426M | 535.5M | 559.5M | 469M | 433M | 468.25M |
Other Investing Acitivies | n/a | 7.61M | 53.63M | 58.13M | 87.05M | 120.46M | 74.44M | -25.07M | 9.46M | -21.51M | 19.25M | 190.71M | 120.62M | 174.06M | 242.96M | -164.18M | -250.57M | -134.3M |
Investing Cash Flow | 56.33M | 58.86M | 77.79M | 58.88M | 79.73M | 111.18M | 129.65M | 28.9M | 60.77M | 28.2M | 2.9M | 167.66M | 88.38M | 125.08M | 181.21M | -226.05M | -302.03M | -165.98M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 7.23M | 5.65M | 241K | 201K | 178K | 1.62M | 2.25M | 2.16M | 127.67M | 130.19M | 132.26M | 135.54M | 12.94M | 15.28M | 26.72M | 29.69M | 30.64M | 30.65M |
Financial Cash Flow | 7.23M | 5.65M | 241K | 201K | 178K | 1.62M | 2.25M | 2.16M | 127.67M | 130.19M | 132.26M | 135.54M | 12.94M | 15.28M | 27.15M | 30.12M | 303.23M | 303.24M |
Net Cash Flow | -13.94M | -17.88M | -14.22M | -47.62M | -49.39M | -22.74M | -24.44M | -128.35M | 33.3M | -20.26M | -48.77M | 95.45M | -107.47M | -58.58M | 15.63M | -374.68M | -181.25M | -39.06M |
Free Cash Flow | -82.81M | -88.75M | -98.88M | -114.53M | -136.59M | -144.81M | -167.02M | -171.35M | -169.73M | -194.84M | -200.29M | -230.8M | -241.03M | -247.92M | -254.47M | -240.62M | -233.92M | -208M |